Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer

Circulating tumor DNA (ctDNA) isolated from plasma has great potential in identification of gene mutation in non-small cell lung cancers (NSCLC), which is a non-invasive technique and can avoid the inherent shortcomings of tissue biopsy. However the ability of NGS to detect gene mutation in plasma c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Yu, Liu, Jinghao, Li, Lei, Yuan, Yuan, Nan, Kejun, Wu, Xin, Zhang, Zhenyu, Wu, Yi, Li, Xin, Zhu, Jiaqi, Meng, Xuehong, Wei, Longgang, Chen, Jun, Jiang, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356786/
https://www.ncbi.nlm.nih.gov/pubmed/27791985
http://dx.doi.org/10.18632/oncotarget.12883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356786/
https://www.ncbi.nlm.nih.gov/pubmed/27791985
http://dx.doi.org/10.18632/oncotarget.12883

Ejemplares similares